ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,424.80
      0.12%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.785
      1.05%
      Bitcoin
      65,251.78
      -1.86%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Therapeutics Acquisition Corp (RACA)

      7. Therapeutics Acquisition Corp (RACA) News

      RACA

      Therapeutics Acquisition (RACA)

      Therapeutics Acquisition Corp
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RACA
      DateTimeSourceHeadlineSymbolCompany
      08/12/20228:23AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RACATherapeutics Acquisition Corp
      08/12/20228:20AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RACATherapeutics Acquisition Corp
      07/12/20226:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RACATherapeutics Acquisition Corp
      07/01/20224:14PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RACATherapeutics Acquisition Corp
      06/06/20224:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
      06/06/20224:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
      06/06/20224:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
      06/06/20224:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
      05/26/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
      05/16/20228:28AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RACATherapeutics Acquisition Corp
      05/16/20228:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RACATherapeutics Acquisition Corp
      05/13/20228:19AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RACATherapeutics Acquisition Corp
      05/13/20228:18AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RACATherapeutics Acquisition Corp
      05/12/20228:43AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RACATherapeutics Acquisition Corp
      04/28/20228:37AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RACATherapeutics Acquisition Corp
      04/05/202210:49AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
      03/31/20225:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
      03/31/20225:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
      03/31/20225:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
      03/31/20225:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
      03/31/20225:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
      03/29/20226:10AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RACATherapeutics Acquisition Corp
      03/25/20228:26AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:RACATherapeutics Acquisition Corp
      03/25/20228:23AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RACATherapeutics Acquisition Corp
      03/17/20227:20PMEdgar (US Regulatory)Amended Annual Statement of Changes in Beneficial Ownership (5/a)NASDAQ:RACATherapeutics Acquisition Corp
      02/25/20228:40AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RACATherapeutics Acquisition Corp
      02/25/20228:39AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RACATherapeutics Acquisition Corp
      02/15/20224:19PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RACATherapeutics Acquisition Corp
      02/15/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RACATherapeutics Acquisition Corp
      02/15/20226:10AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RACATherapeutics Acquisition Corp
       Showing the most relevant articles for your search:NASDAQ:RACA